Cholangiocarcinoma
📧 Sign up to get email alerts when something new happens for Cholangiocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-04-13Clinical Trial Update: Beacon BNX™ Endoscopic Ultrasound (EUS)-Needle vs SharkCore™ Needle [NA]
A clinical trial comparing Beacon BNX EUS-Needle vs SharkCore Needle has been withdrawn. The study involved pancreatic cancer, lymphadenopat…
-
CLINICAL_TRIALS withdrawal · 2025-09-11Clinical Trial Update: A Phase II Study of Adjuvant Immunotherapy Targeting KRAS G12D, KRAS G12V, or TP53 R175H for Participants With Advanced Gastrointestinal Malignancies [Phase 2]
A Phase II clinical trial investigating adjuvant immunotherapy targeting KRAS G12D, KRAS G12V, and TP53 R175H across several gastrointestina…
-
CLINICAL_TRIALS withdrawal · 2025-07-30Clinical Trial Update: HLA Typing & Tumor Neoantigen Identification for Phase I/II Study of Autologous TCR-T Cells in Subjects With Solid Tumors
Alaunos Therapeutics reports termination of a Phase I/II autologous TCR-T cell trial across several solid tumors. The study focused on HLA t…
-
CLINICAL_TRIALS withdrawal · 2024-06-12Clinical Trial Update: Implementing Acupuncture and Chinese Herbal Medicine Into Palliative Care [NA]
The clinical trial evaluating acupuncture and Chinese herbal medicine in palliative care for cancer patients has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2023-05-03Clinical Trial Update: Anesthetic Agents and Acute Kidney Injury After Liver Resection Surgery [Phase 4]
A Phase 4 clinical trial evaluating anesthetic agents and acute kidney injury after liver resection has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA withdrawal · 2023-01-30EMA Application withdrawn: Febseltiq (Infigratinib monophosphate) — Helsinn Birex Pharmaceuticals Ltd
Application withdrawn for Febseltiq (Infigratinib monophosphate) by Helsinn Birex Pharmaceuticals Ltd in relation to cholangiocarcinoma.
-
CLINICAL_TRIALS withdrawal · 2017-10-27Clinical Trial Update: Study of Sildenafil as a Therapy for Fatigue in Pancreatic Cancer [Phase 1]
A Phase 1 trial evaluating sildenafil for fatigue in pancreatic cancer (and cholangiocarcinoma) has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-05-30Clinical Trial Update: Ricolinostat, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable or Metastatic Cholangiocarcinoma [Phase 1]
This Phase 1 trial of ricolinostat with gemcitabine and cisplatin for unresectable or metastatic cholangiocarcinoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-05-04Clinical Trial Update: Coregistration of 18F-FDG-PET and MRI in the Staging of Potentially Resectable Hilar Cholangiocarcinoma: a Pilot Study
A pilot trial investigating co-registration of 18F-FDG-PET and MRI for staging potentially resectable hilar cholangiocarcinoma was withdrawn…
-
CLINICAL_TRIALS withdrawal · 2017-04-18Clinical Trial Update: Capecitabine and Y-90 Radioembolization in Treating Patients With Advanced Bile Duct Cancer in the Liver That Cannot Be Removed by Surgery [Phase 1]
A Phase 1 trial of Capecitabine plus Y-90 radioembolization for advanced intrahepatic cholangiocarcinoma (bile duct cancer) that cannot be s…
-
CLINICAL_TRIALS withdrawal · 2017-01-26Clinical Trial Update: Use of the EnLightTM and LightPathTM Imaging Systems in Gastrointestinal Tumour Surgery
A clinical trial assessing the EnLight and LightPath imaging systems for gastrointestinal tumor surgery has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-04-26Clinical Trial Update: Comparison Between Unilateral Versus Bilateral Stenting for Malignant Hilar Biliary Obstruction to Use a LCD Stent [NA]
A clinical trial comparing unilateral versus bilateral stenting for malignant hilar biliary obstruction using an LCD stent has been withdraw…
-
CLINICAL_TRIALS withdrawal · 2016-04-26Clinical Trial Update: Comparison Between Two Methods of Bilateral Stenting for Malignant Hilar Obstruction [Phase 3]
A Phase 3 trial evaluating two methods of bilateral stenting for malignant hilar obstruction has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-09-17Clinical Trial Update: BKM120 in Cancers With PIK3CA Activating Mutations [Phase 2]
A Phase 2 trial of buparlisib (BKM120) in cancers with activating PIK3CA mutations has been withdrawn. The conditions listed include lung ca…
-
CLINICAL_TRIALS withdrawal · 2015-06-03Clinical Trial Update: Comparison of Biliary Stenting Alone vs. Stenting With Photodynamic Therapy (PDT) During ERCP
A clinical trial comparing biliary stenting alone to biliary stenting with photodynamic therapy for cholangiocarcinoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-09-09Clinical Trial Update: Selumetinib and Akt Inhibitor MK-2206 in Treating Patients With Refractory or Advanced Gallbladder or Bile Duct Cancer That Cannot Be Removed By Surgery [Phase 2]
A Phase 2 study of selumetinib combined with MK-2206 for refractory or advanced gallbladder and biliary tract cancers has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-08-10Clinical Trial Update: Gemcitabine/Oxaliplatin and Photodynamic Therapy in Cholangiocarcinoma [Phase 2]
A Phase 2 trial of gemcitabine and oxaliplatin with photodynamic therapy for cholangiocarcinoma has been withdrawn.